Skin Care Tips & Tricks

Confused on where to start with skin care?
You aren’t alone. There are so many products available that it is not easy to find what will work for you. Here are a few tips and tricks to know what to look for and where to begin.

Where are you purchasing your products?

Purchasing your skin care products from your Facial Plastic Surgeon’s office (Lakeside Cosmetic Center) will guarantee ingredients that will enhance your skin with less buffers and more science. We work directly with the high quality skin care companies who not just stand behind their products, but provide studies and research to prove their products work. Bonus: High quality skin care products last longer because you need less to apply to your skin since there are quality ingredients.

What are your skin care needs?

With so many products out there, how do you know what to use? You need to decide what you want to address. Is your skin dry from the winter blues or are you trying to stay one step ahead of natural aging? Do you want to maintain your skin’s glow between HydraFacials? Are those pesky breakouts stressing you out?

Why do you need a full regimen?

There are certain products that work best in the am vs the pm. You want to apply products in the proper order for better absorption and to know which ingredients address different skin care concerns. If you are a beginner to the skin care world, keep it simple and consistent. Cleanse, Treat, Moisturize, Protect.

How do you know what ingredients to look for?

Some key ingredients to look for are: growth factors, peptides, antioxidants, hyaluronic acid, retinol, zinc oxide and titanium dioxide. These individual ingredients can build a solid foundation of youthful and more importantly healthy skin. Our expert staff is highly trained and dedicated to provide you a clear understanding of your new skin care regimen and the steps. Every patient who purchases a product also leaves with a customized skin care regimen card.

So now you know where to start, your next step is scheduling the Consult! Give one of our Patient Care Coordinators a call at (585) 905-3414.

Interested in other Treatments or Procedures?

Connect with us:
IG: @chelseaobournmd
Facebook: Lakeside Cosmetic Center

What is the difference between facial fillers and BOTOX®?

This is a common question! BOTOX® is a purified neurotoxin. It is utilized to temporarily paralyze muscles in the face that are associated with wrinkling. Through deliberate and precise placement of BOTOX®, we are able to effectively soften moderate to severe wrinkles. Typical treatment areas include the glabella (the area between the eyebrows), the forehead, crowsfeet, bunny lines, vertical wrinkles around the lips, wrinkling of the chin, and more. Facial filler, on the other hand, is used to replace and restore volume in areas of loss. The most commonly used fillers these days are hyaluronic acid, a naturally occurring component of the skin. Commonly treated areas include the cheeks, nasolabial folds, marionette lines, tear troughs, and lips. Through careful and skillful placement of the filler, a softer, more rejuvenated look can be achieved.

What is Botox®?

Botox® (botulinum toxin type A) is a purified neurotoxin utilized to temporarily paralyze muscles in the face associated with moderate to severe wrinkling. It is a form of the same toxin produced by the microbe which causes Botulism. Although this can sound scary, the amount used to treat facial wrinkles is very minute and very safe. It works by causing a chemical denervation at the motor nerve terminals resulting in a reduction of muscular activity. It acts very locally and is not expected to be absorbed systemically. Botox® is now FDA approved for treatment of forehead lines, crow’s feet lines, and frown lines between the eyebrows. Utilized correctly and by an experienced provider, it can help create a softer, smoother, more rejuvenated look. Our motto is to only give you what you need and to stay away from the frozen or overdone look.

For more information, follow the attached link:

Before – Day 1:









After – Day 7:





Important Botox® Information:




BOTOX® Cosmetic (onabotulinumtoxinA) Important Information


BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of: – moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity – moderate to severe lateral canthal lines associated with orbicularis oculi activity – moderate to severe forehead lines associated with frontalis activity



Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.

CONTRAINDICATIONS BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.

WARNINGS AND PRECAUTIONS Lack of Interchangeability between Botulinum Toxin Products

The potency Units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.

Spread of Toxin Effect Please refer to Boxed Warning for Distant Spread of Toxin Effect. No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported.

Serious Adverse Reactions With Unapproved Use Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.

Hypersensitivity Reactions Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.

Cardiovascular System There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.

Increased Risk of Clinically Significant Effects with Pre-existing Neuromuscular Disorders Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).

Dysphagia and Breathing Difficulties Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).

Pre-existing Conditions at the Injection Site Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).

Human Albumin and Transmission of Viral Diseases This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.

ADVERSE REACTIONS The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for glabellar lines was eyelid ptosis (3%).

The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).

The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%) and eyelid ptosis (2%).

DRUG INTERACTIONS Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.

The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.

Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.

USE IN SPECIFIC POPULATIONS There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.

Please see BOTOX® Cosmetic Full Prescribing Information including Boxed Warning and Medication Guide.

What is Facial Plastic and Reconstructive Surgery?

Facial Plastic and Reconstructive Surgery is a surgical specialty focused on treating the functional and cosmetic physical defects of the head and neck. Typically, a Facial Plastic Surgeon has undergone rigorous training that includes 4 years of medical school, followed by 5 years of residency in Otolaryngology – Head and Neck Surgery, and 1 year of fellowship in Facial Plastic Surgery. This means that a Facial Plastic Surgeon’s surgical training is focused solely on the intricate anatomy of the head and neck.

Some procedures performed by these Surgeons include:

  • Upper and lower eyelid blepharoplasty
  • Browlift
  • Chin augmentation
  • Earlobe repair
  • Earlobe reduction
  • Fat transfer to restore volume to the face
  • Facelift
  • Neck-lift
  • Otoplasty
  • Rhinoplasty
  • Skin cancer treatment and repair
  • Facial trauma

Non-surgical rejuvenation of the face is also an important aspect of a Facial Plastic Surgeon’s practice. Usualy this involves an emphasis on skin care, using laser, chemical peels, etc, as well as the use of botox and fillers to restore and rejuvenate the face.